D. Sarantakis

1.0k total citations
22 papers, 804 citations indexed

About

D. Sarantakis is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, D. Sarantakis has authored 22 papers receiving a total of 804 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Cellular and Molecular Neuroscience and 3 papers in Organic Chemistry. Recurrent topics in D. Sarantakis's work include Neuropeptides and Animal Physiology (5 papers), Chemical Synthesis and Analysis (4 papers) and Growth Hormone and Insulin-like Growth Factors (3 papers). D. Sarantakis is often cited by papers focused on Neuropeptides and Animal Physiology (5 papers), Chemical Synthesis and Analysis (4 papers) and Growth Hormone and Insulin-like Growth Factors (3 papers). D. Sarantakis collaborates with scholars based in United States, Canada and Netherlands. D. Sarantakis's co-authors include Norman H. Grant, Victor M. Garsky, Larry Stein, C. David Wise, James D. Belluzzi, W. Herbert McGregor, Eric L. Lien, Ian C. P. Smith, Richard L. Fenichel and V M Garsky and has published in prestigious journals such as Nature, Biochemistry and Biochemical and Biophysical Research Communications.

In The Last Decade

D. Sarantakis

22 papers receiving 690 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Sarantakis United States 10 530 525 228 75 68 22 804
Pier Carlo Montecucchi Italy 10 494 0.9× 527 1.0× 138 0.6× 35 0.5× 115 1.7× 16 928
Michiko Asai Japan 4 952 1.8× 1.3k 2.5× 159 0.7× 79 1.1× 89 1.3× 4 1.7k
D. Roemer Japan 8 461 0.9× 436 0.8× 189 0.8× 20 0.3× 40 0.6× 14 673
D. B. Hope United Kingdom 22 295 0.6× 372 0.7× 283 1.2× 60 0.8× 146 2.1× 53 1.4k
Hartmut Berger Germany 16 174 0.3× 330 0.6× 172 0.8× 49 0.7× 83 1.2× 25 624
G. Gacel France 23 1.3k 2.5× 1.2k 2.2× 411 1.8× 19 0.3× 57 0.8× 52 1.6k
P.F.M. Janssen Belgium 13 736 1.4× 578 1.1× 129 0.6× 15 0.2× 30 0.4× 20 1.1k
D. D. Wheeler United States 18 596 1.1× 384 0.7× 137 0.6× 51 0.7× 11 0.2× 44 844
A. W. Lipkowski United States 13 853 1.6× 734 1.4× 293 1.3× 34 0.5× 14 0.2× 34 1.1k
Victor J. Hruby United States 17 874 1.6× 1.1k 2.0× 217 1.0× 18 0.2× 18 0.3× 33 1.4k

Countries citing papers authored by D. Sarantakis

Since Specialization
Citations

This map shows the geographic impact of D. Sarantakis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Sarantakis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Sarantakis more than expected).

Fields of papers citing papers by D. Sarantakis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Sarantakis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Sarantakis. The network helps show where D. Sarantakis may publish in the future.

Co-authorship network of co-authors of D. Sarantakis

This figure shows the co-authorship network connecting the top 25 collaborators of D. Sarantakis. A scholar is included among the top collaborators of D. Sarantakis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Sarantakis. D. Sarantakis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bex, Frederick J., Alan Corbin, D. Sarantakis, & Eric L. Lien. (1981). Absence of luteinizing hormone-releasing and anti-fertility properties in a glucagon-selective somatostatin analogue. Nature. 291(5817). 672–673. 2 indexed citations
2.
Sarantakis, D., et al.. (1978). [des‐ALA1, GLY2]‐His4,5 D‐TRP8 ‐somatostatin. FEBS Letters. 92(2). 153–155. 7 indexed citations
3.
Tancrède, Pierre, Roxanne Deslauriers, W. Herbert McGregor, et al.. (1978). A carbon-13 nuclear magnetic resonance study of the molecular dynamics of methionine-enkephalin and .alpha.-endorphin in aqueous solution. Biochemistry. 17(14). 2905–2914. 25 indexed citations
4.
Sarantakis, D., et al.. (1977). A bicyclo-somatostatin analog, highly specific for the inhibition of growth hormone release. Biochemical and Biophysical Research Communications. 75(1). 143–148. 3 indexed citations
5.
Belluzzi, James D., Norman H. Grant, Victor M. Garsky, et al.. (1976). Analgesia induced in vivo by central administration of enkephalin in rat. Nature. 260(5552). 625–626. 436 indexed citations
6.
Grant, Norman H., et al.. (1976). Dissociation of somatostatin effects. Peptides inhibiting the release of growth hormone but not glucagon or insulin in rats. Life Sciences. 19(5). 629–631. 18 indexed citations
7.
Lien, Eric L., Richard L. Fenichel, V M Garsky, D. Sarantakis, & Norman H. Grant. (1976). Enkephalin-stimulated prolactin release. Life Sciences. 19(6). 837–840. 107 indexed citations
8.
Deslauriers, Roxanne, George C. Levy, W. Herbert McGregor, D. Sarantakis, & Ian C. P. Smith. (1975). Conformational flexibility of luteinizing hormone-releasing hormone in aqueous solution. Carbon-13 spin-lattice relaxation time study. Biochemistry. 14(19). 4335–4343. 48 indexed citations
9.
Grant, Norman H., D. Sarantakis, & John P. Yardley. (1974). ACTION OF GROWTH HORMONE RELEASE INHIBITORY HORMONE ON PROLACTIN RELEASE IN RAT PITUITARY CELL CULTURES. Journal of Endocrinology. 61(1). 163–164. 18 indexed citations
11.
Smith, Ian C. P., Roxanne Deslauriers, Hazime Saitô, et al.. (1973). CARBON‐13 NMR STUDIES OF PEPTIDE HORMONES AND THEIR COMPONENTS *. Annals of the New York Academy of Sciences. 222(1). 597–627. 24 indexed citations
12.
Wied, D. de, D. Sarantakis, & B. Weinstein. (1973). Behavioural evaluation of peptides related to scotophobin. Neuropharmacology. 12(12). 1109–1115. 11 indexed citations
13.
Sarantakis, D., et al.. (1972). Amino acids and peptides. 34. Synthesis of a structure related to scotophobin.. PubMed. 4(6). 395–404. 7 indexed citations
14.
Sarantakis, D., et al.. (1972). AMINO ACIDS AND PEPTIDES. International journal of peptide & protein research. 4(6). 395–404. 7 indexed citations
15.
Sarantakis, D., et al.. (1971). Synthesis of a structure proposed for scotophobin. Cellular and Molecular Life Sciences. 27(10). 1138–1139. 12 indexed citations
16.
Sarantakis, D., et al.. (1971). Oxidation of substituted carbodiimides and ureas. Tetrahedron. 27(12). 2573–2578. 1 indexed citations
17.
Sarantakis, D., et al.. (1971). Synthesis of the natural product (±)-dictyopterene B. Journal of the Chemical Society D Chemical Communications. 0(16). 940a–940a. 2 indexed citations
18.
Sarantakis, D., et al.. (1971). O-Acyl-N-hydroxyureas as Acylating Agents. Synthesis. 1971(6). 328–328. 1 indexed citations
19.
Sarantakis, D., et al.. (1968). 2-Fluoropyridine N-oxide and its reactions with amino-acid derivatives. Journal of the Chemical Society C Organic. 1. 72–72. 3 indexed citations
20.
Sarantakis, D., et al.. (1966). 2-Fluoropyridine N-oxide in peptide chemistry. Chemical Communications (London). 105–105. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026